CRISPR/Cas9induced saturated mutagenesis identifies Rad51 haplotype as a marker of PARP inhibitor sensitivity in breast cancer.

Yang H, Wei Y, Zhang Q, Yang Y, Bi X, Yang L, Xiao N, Zang A, Ren L, Li X
Mol Med Rep. 2022 Aug;26(2). pii: 258. doi: 10.3892/mmr.2022.12774. Epub 2022 Jun 17. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.